Accuracy of Commercially Available Heart Rate Monitors III

October 17, 2017 updated by: Marc Gillinov, MD, The Cleveland Clinic

Accuracy of Commercially Available Heart Rate Monitors in Cardiac Rehabilitation Patients: A Prospective, Randomized Study

The objective of this study is to evaluate the accuracy of four heart rate monitors in cardiac rehabilitation patients during typical, supervised cardiac rehabilitation involving exercise on a treadmill and/or stationary bicycle.

Study Overview

Detailed Description

This study will assess the accuracy of four of the best-selling optical heart rate monitors when worn by cardiac rehabilitation patients.

During testing, each subject will wear:

  1. Two different optical heart rate monitors (one on each wrist)
  2. A Polar chest-strap based monitor
  3. ECG leads

The types of wrist-worn heart rate monitors assigned to each subject will be randomly assigned.

The location (left or right wrist) will also be randomly assigned.

Heart rate will be assessed using each of the 4 monitors with the subject on the exercise machines under each of the following conditions:

  1. Pre-exercise
  2. Treadmill: at 3, 5 and 7 min.
  3. Stationary Cycle: at 3, 5 and 7 min.

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Cleveland, Ohio, United States, 44195
        • Cleveland Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age > 18 years
  • Patients enrolled in cardiac rehabilitation program at Cleveland Clinic Main Campus

Exclusion Criteria:

  • Presence of a cardiac pacemaker
  • Known chronic and persistent heart rhythm disorders
  • Tattoos around the wrist or forearm area
  • Use of a radial artery graft for coronary artery bypass grafting

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Fit Bit Blaze
Fit Bit Blaze Heart Rate Monitoring Device
Fit Bit Blaze Heart Rate Monitoring Device
Garmin Forerunner 235 Heart Rate Monitoring Device
Tom Tom Spark Cardio Heart Rate Monitoring Device
Apple Watch Heart Rate Monitoring Device
Active Comparator: Garmin Forerunner 235
Garmin Forerunner 235 Heart Rate Monitoring Device
Fit Bit Blaze Heart Rate Monitoring Device
Garmin Forerunner 235 Heart Rate Monitoring Device
Tom Tom Spark Cardio Heart Rate Monitoring Device
Apple Watch Heart Rate Monitoring Device
Active Comparator: Tom Tom Spark Cardio
Tom Tom Spark Cardio Heart Rate Monitoring Device
Fit Bit Blaze Heart Rate Monitoring Device
Garmin Forerunner 235 Heart Rate Monitoring Device
Tom Tom Spark Cardio Heart Rate Monitoring Device
Apple Watch Heart Rate Monitoring Device
Active Comparator: Apple Watch
Apple Watch Heart Rate Monitoring Device
Fit Bit Blaze Heart Rate Monitoring Device
Garmin Forerunner 235 Heart Rate Monitoring Device
Tom Tom Spark Cardio Heart Rate Monitoring Device
Apple Watch Heart Rate Monitoring Device

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart Rate Monitor Accuracy Compared to ECG
Time Frame: 16 minutes
The primary outcome measure is the accuracy of each heart rate monitor compared to ECG. This will be expressed by the correlation coefficient.
16 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Marc Gillinov, MD, The Cleveland Clinic

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 22, 2017

Primary Completion (Actual)

October 11, 2017

Study Completion (Actual)

October 11, 2017

Study Registration Dates

First Submitted

June 7, 2017

First Submitted That Met QC Criteria

June 7, 2017

First Posted (Actual)

June 9, 2017

Study Record Updates

Last Update Posted (Actual)

October 19, 2017

Last Update Submitted That Met QC Criteria

October 17, 2017

Last Verified

October 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • 17-661

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiac Rehabilitation

Clinical Trials on Fit Bit Blaze

Subscribe